Is Xeris Biopharma Holdings, Inc. (XERS) a Buy, Sell, or Hold?
Xeris Biopharma Holdings, Inc.
NASDAQ:XERS
$8.7 USD
$0.42 (5.07%)
- Volume
- 1.38M
- Average Volume
- 1.88M
- Market Capitalization
- $1.5B
- P/E Ratio
- 122.88
- Dividend Yield
- 0.00%
- Price Target
- $6.60
- Year High
- $10.08
- Year Low
- $4.87
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.12
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
31.8% UPSIDE
$6.60 Price Target
UPSIDE/DOWNSIDE HIGH
-51.7% DOWNSIDE
$18.00 Price Target High
UPSIDE/DOWNSIDE LOW
117.5% UPSIDE
$4.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Oppenheimer | Leland Gershell | $18 | $9.97 | 2025-10-29 08:14 AM | 80.5% |
| H.C. Wainwright | Oren Livnat | $6.6 | $3.245 | 2024-11-11 07:23 AM | 103.4% |
| Oppenheimer | Leland Gershell | $5 | $3.02 | 2024-10-23 02:18 AM | 65.6% |
| Piper Sandler | David Amsellem | $3 | $1.8469 | 2024-05-10 04:29 AM | 62.4% |